InvestorsHub Logo
Post# of 428
Next 10
Followers 0
Posts 12555
Boards Moderated 1
Alias Born 12/10/2004

Re: None

Monday, 03/20/2006 1:18:00 AM

Monday, March 20, 2006 1:18:00 AM

Post# of 428
XKEM ---- ALERT ---- LAST minute --- XKEM facility in Nigeria -DRUG
ready to produce . Approval anytime !
..............................MEGA BUY CONFIRM XKEM ready to EXPLODE WIN 1000% - LAst time to PICK UP
UNDER 0.02 cents !


Pictures of Xechem Nigeria production facility * Shestco facility

www.SHESTCO.org

Sounds like they are ready to start production of Nicosan.June looks
like the starting date IMO They are in the advanced stages of
completing of this 8.5 million dollar facility.Pictures look like
it's ready to go!


I've just been convinced that this is gonna roll in June.This
website is just up & running I believe.We should be able to get
updates from this website on Xechems progress? STRONG BUY
MONDAY!!!!!!

Now remember this: March 3rd, 2006 Obasanjo to launch locally
produced sickle cell drug

President Olusegun Obasanjo will by June launch NIPRISAN (HEMOXIN
(TM)), the locally produced drug for sickle cell disorder.
PATIENCE OGBE Abuja

The president will also use the occasion This is the ocassion
http://allafrica.com/stories/200603030452.html

to commission Xechem International Inc. factory in the country in a
move seen as a landmark investment in Nigeria. The company owns the
exclusive rights to NIPRISAN

The drug NIPRISAN (HEMOXIN(TM), which is at present, undergoing
final stage of registration with NAFDAC is a phyto-pharmaceutical
drug for the treatment of patients suffering from Sickle Cell
Disease (SCD). SCD is an insidious and painful genetic blood
disorder often resulting in death at an early age.

Science and Technology Minister, Turner Isoun who disclosed this in
Abuja noted that location of the factory in Nigeria would further
crash the price of sickle cell drugs in Nigeria.

Isoun stated that Niprisan (HEMOXIN(TM)) was a drug cocktail, with
phyto-pharmaceutical composition of four traditional plants
extracted in a proprietary process. The licensor of the technology
is the National Institute for Pharmaceutical Research and
Development (NIPRD) in Abuja, Nigeria.

Nigeria is said to have the highest sickle cell disease population
in the world ranging from four to six million representing roughly
three to five percent of the country's population.

Isoun spoke at the inaugural meeting of the Ministers' Council for
the National Biotechnology Development Agency (NABDA) where he also
called on the government to involve more laboratories for the
control and analysis of the bird flu menace.

On the situation of bio technology in Nigeria, he called on the
stockholding agencies to ensure that Nigeria benefits from the
judicious and safe use of modern biotechnology.

"Biotech is a gold mine and important to this nation. Almost every
Nigerian is affected by the operations of biotech. To be able to
achieve all these, we will require the concerted political will and
a focused leadership drive. It is therefore the collective
responsibility of all of us key stakeholders of modern biotechnology
to join forces in realizing this vision.

It is my belief that this collective mission will not jeopardize our
separate mandates but will promote the effective coordination of our
effort towards achieving the same ultimate goal."

To achieve the nation's targets in biotech, the Director General of
the National Biotechnology Development Agency (NABDA), Bamidele
Solomon called for the establishment of biotechnology development
fund.

The fund, he stressed, could help the nation support competent
researches and be ready to tackle problems like the bird flu.

He also disclosed that Nigeria in collaboration with Trinity Biotech
of the Republic of Ireland will establish a facility at SHESTCO
Abuja for the production of test kits for HIV/AIDS and other
diseases like HB, malaria and so on.

He added that the Federal Government has approved the sum of $28
million as counterpart commitment for the project.

He also spoke of Nigeria's collaboration with Shantha Biotechnics
Limited of India for the establishment a facility for the production
of Hepatitis B vaccine and other vaccines for related diseases like
typhoid, polio, DTP and related ailments.

"Government approved the sum of N10 Million in the 2004 capital
budget to support carrying out of a detailed feasibility study and
fulfilling other MoU requirement."




XKEM in addition to myself talking to Stephen Burg IR of XKEM


NIZ,The Govt Is Under Alot Of Pressure To Get The Drug Approved ASAP.
I Talked To Steve Today And He Said The Factory Is Built And All The
Supplies And Personel Are Ready To Go And That Revs Start From Day 1.
All We Need Is That Green Light. The Nigerian Govt Will Pay For The
Drug And Distribute It. We Are Babies Breath Away.














Live for Today - Learn for Tomorrow

Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.